|
|
Article: Molecular Insight Pharmaceuticals, Inc. Announces Appointment of Norman LaFrance, M.D., as Senior Vice President, Clinical Development and Chief Medical Officer.
- Article from:
- Business Wire
- Article date:
- April 23, 2007
CopyrightCOPYRIGHT 2007 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
CAMBRIDGE, Mass. -- Molecular Insight Pharmaceuticals (NASDAQ: MIPI) announced today the appointment of Norman LaFrance, M.D., to the position of Senior Vice President, Clinical Development and Chief Medical Officer. He joins Molecular Insight after a nearly 20-year industry career at DuPont-Merck, Bracco Diagnostics, Celltech, and most recently Bausch & Lomb, where he was Vice President, Global Pharmaceutical R&D.
"We believe that Norman's extensive and distinguished track record of pharmaceutical research and development, combined with his specific expertise in nuclear medicine, should enable him to make meaningful and immediate contributions to our company," ...
Related newspaper, magazine, and journal articles:
|
|
Article: Molecular Insight Pharmaceuticals, Inc. Announces ...
Business Wire;
March 31, 2008 ;
700+ words
... ... position of Senior Vice President, Clinical Development ... Abeysekera, Ph.D., as Vice President, Manufacturing; and Christine Huh as Vice President, Human Resources ... M.D., to the Molecular Insight Board of Directors ...
|
|